Dowregulation of OTX1 attenuates gastric cancer cell proliferation, migration and invasion

Qin,Shi‑Chen; Zhao,Zhong; Sheng,Jin‑Xin; Xu,Xiang‑Hui; Yao,Jie; Lu,Jin‑Jun; Chen,Bin; Zhao,Guo‑Dong; Wang,Xiao‑Yong; Yang,Yan‑Dong

doi:10.3892/or.2018.6596

Dowregulation of OTX1 attenuates gastric cancer cell proliferation, migration and invasion

Authors:
- Shi‑Chen Qin
- Zhong Zhao
- Jin‑Xin Sheng
- Xiang‑Hui Xu
- Jie Yao
- Jin‑Jun Lu
- Bin Chen
- Guo‑Dong Zhao
- Xiao‑Yong Wang
- Yan‑Dong Yang
View Affiliations

Affiliations: Department of General Surgery, Haimen People's Hospital, Haimen, Jiangsu 226100, P.R. China
Published online on: July 24, 2018 https://doi.org/10.3892/or.2018.6596
Pages: 1907-1916
Copyright: © Qin et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Orthodenticle homolog 1 (OTX1) has previously been revealed to be tightly associated with the development and progression of several human tumors. However, the functional roles and underlying molecular mechanisms of OTX1 in gastric cancer (GC) remain poorly understood. In the present study, we observed that OTX1 was highly expressed in GC tissues compared with adjacent non‑tumor tissues based on a large cohort of samples from The Cancer Genome Atlas (TCGA) database. An immunohistochemical analysis indicated that OTX1 levels were increased in tumors that became metastatic compared with those in tumors that did not. This finding was significantly associated with patients who had shorter overall survival times. The knockdown of OTX1 significantly inhibited the proliferation, migration and invasion of SGC‑7901 and MGC‑803 cells. Furthermore, the knockdown of OTX1 induced cell cycle arrest in the G0/G1 phase and reduced the expression of cyclin D1. In addition, the inhibition of OTX1 led to increased GC cell apoptosis by upregulating cleaved PARP, cleaved caspase‑3 and Bax. In conclusion, our data indicated that OTX1 functions as a key regulator in tumor growth and metastasis of GC cells. Thus, OTX1 may be a promising novel target for molecular therapy directed toward GC.

View Figures

View References

1	Wang J, Yu JC, Kang WM and Ma ZQ: Treatment strategy for early gastric cancer. Surg Oncol. 21:119–123. 2012. View Article : Google Scholar : PubMed/NCBI
2	Siegel R, Ma J, Zou Z and Jemal A: Cancer statistics, 2014. CA Cancer J Clin. 64:9–29. 2014. View Article : Google Scholar : PubMed/NCBI
3	Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D: Global cancer statistics. CA Cancer J Clin. 61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
4	Nonoshita T, Otsuka S, Inagaki M and Iwagaki H: Complete response obtained with S-1 plus CDDP therapy in a patient with multiple liver metastases from gastric cancer. Hiroshima J Med Sci. 64:65–69. 2015.PubMed/NCBI
5	Tong W, Ye F, He L, Cui L, Cui M, Hu Y, Li W, Jiang J, Zhang DY and Suo J: Serum biomarker panels for diagnosis of gastric cancer. Onco Targets Ther. 9:2455–2463. 2016.PubMed/NCBI
6	Chang JS, Kim KH, Keum KC, Noh SH, Lim JS, Kim HS, Rha SY, Lee YC, Hyung WJ and Koom WS: Recursive partition analysis of peritoneal and systemic recurrence in patients with gastric cancer who underwent D2 gastrectomy: Implications for neoadjuvant therapy consideration. J Surg Oncol. 114:859–864. 2016. View Article : Google Scholar : PubMed/NCBI
7	Thrumurthy SG, Chaudry MA, Chau I and Allum W: Does surgery have a role in managing incurable gastric cancer? Nat Rev Clin Oncol. 12:676–682. 2015. View Article : Google Scholar : PubMed/NCBI
8	Klein WH and Li X: Function and evolution of Otx proteins. Biochem Biophys Res Commun. 258:229–233. 1999. View Article : Google Scholar : PubMed/NCBI
9	Omodei D, Acampora D, Russo F, De Filippi R, Severino V, Di Francia R, Frigeri F, Mancuso P, De Chiara A, Pinto A, et al: Expression of the brain transcription factor OTX1 occurs in a subset of normal germinal-center B cells and in aggressive non-hodgkin lymphoma. Am J Pathol. 175:2609–2617. 2009. View Article : Google Scholar : PubMed/NCBI
10	Larsen KB, Lutterodt M, Rath MF and Møller M: Expression of the homeobox genes PAX6, OTX2, and OTX1 in the early human fetal retina. Int J Dev Neurosci. 27:485–492. 2009. View Article : Google Scholar : PubMed/NCBI
11	Pagani IS, Terrinoni A, Marenghi L, Zucchi I, Chiaravalli AM, Serra V, Rovera F, Sirchia S, Dionigi G, Miozzo M, et al: The mammary gland and the homeobox gene Otx1. Breast J. 16 Suppl:S53–S56. 2010. View Article : Google Scholar : PubMed/NCBI
12	de Haas T, Oussoren E, Grajkowska W, Perek-Polnik M, Popovic M, Zadravec-Zaletel L, Perera M, Corte G, Wirths O, van Sluis P, et al: OTX1 and OTX2 expression correlates with the clinicopathologic classification of medulloblastomas. J Neuropathol Exp Neurol. 65:176–186. 2006. View Article : Google Scholar : PubMed/NCBI
13	Terrinoni A, Pagani IS, Zucchi I, Chiaravalli AM, Serra V, Rovera F, Sirchia S, Dionigi G, Miozzo M, Frattini A, et al: OTX1 expression in breast cancer is regulated by p53. Oncogene. 30:3096–3103. 2011. View Article : Google Scholar : PubMed/NCBI
14	Yu K, Cai XY, Li Q, Yang ZB, Xiong W, Shen T, Wang WY and Li YF: OTX1 promotes colorectal cancer progression through epithelial-mesenchymal transition. Biochem Biophys Res Commun. 444:1–5. 2014. View Article : Google Scholar : PubMed/NCBI
15	Li H, Miao Q, Xu CW, Huang JH, Zhou YF and Wu MJ: OTX1 contributes to hepatocellular carcinoma progression by regulation of ERK/MAPK pathway. J Korean Med Sci. 31:1215–1223. 2016. View Article : Google Scholar : PubMed/NCBI
16	Chandrashekar DS, Bashel B, Balasubramanya SAH, Creighton CJ, Ponce-Rodriguez I, Chakravarthi BVSK and Varambally S: UALCAN: A portal for facilitating tumor subgroup gene expression and survival analyses. Neoplasia. 19:649–658. 2017. View Article : Google Scholar : PubMed/NCBI
17	Wang N, Wang Q, Shen D, Sun X, Cao X and Wu D: Downregulation of microRNA-122 promotes proliferation, migration, and invasion of human hepatocellular carcinoma cells by activating epithelial-mesenchymal transition. Onco Targets Ther. 9:2035–2047. 2016. View Article : Google Scholar : PubMed/NCBI
18	Mao Y, Zhao Q, Yin S, Ding X and Wang H: Genome-wide expression profiling and bioinformatics analysis of deregulated genes in human gastric cancer tissue after gastroscopy. Asia Pac J Clin Oncol. 14:e29–e36. 2018. View Article : Google Scholar : PubMed/NCBI
19	Ezhevsky SA, Ho A, Becker-Hapak M, Davis PK and Dowdy SF: Differential regulation of retinoblastoma tumor suppressor protein by G(1) cyclin-dependent kinase complexes in vivo. Mol Cell Biol. 21:4773–4784. 2001. View Article : Google Scholar : PubMed/NCBI
20	Boulares AH, Yakovlev AG, Ivanova V, Stoica BA, Wang G, Iyer S and Smulson M: Role of poly(ADP-ribose) polymerase (PARP) cleavage in apoptosis. Caspase 3-resistant PARP mutant increases rates of apoptosis in transfected cells. J Biol Chem. 274:22932–22940. 1999. View Article : Google Scholar : PubMed/NCBI
21	Nieto MA: Epithelial-mesenchymal transitions in development and disease: Old views and new perspectives. Int J Dev Biol. 53:1541–1547. 2009. View Article : Google Scholar : PubMed/NCBI
22	Kalluri R and Weinberg RA: The basics of epithelial-mesenchymal transition. J Clin Invest. 119:1420–1428. 2009. View Article : Google Scholar : PubMed/NCBI